Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
AstraZeneca
Johnson and Johnson
Mallinckrodt
Argus Health
Boehringer Ingelheim
McKinsey
Farmers Insurance
Moodys

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,476,425

« Back to Dashboard

Which drugs does patent 8,476,425 protect, and when does it expire?

Patent 8,476,425 protects ZERBAXA and is included in one NDA.
Summary for Patent: 8,476,425
Title:Tazobactam arginine compositions
Abstract: This disclosure provides compositions containing solid forms of tazobactam arginine, and methods of manufacturing and using these compositions.
Inventor(s): Lai; Jan-Ji (Westborough, MA), Gu; Jian-Qiao (Lexington, MA), Pathare; Pradip M. (Lexington, MA), Jurkauskas; Valdas (Cambridge, MA), Terracciano; Joseph (Concord, MA), Damour; Nicole Miller (Belmont, MA)
Assignee: Cubist Pharmaceuticals, Inc. (Lexington, MA)
Application Number:13/628,742
Patent Claim Types:
see list of patent claims
Composition;

Drugs Protected by US Patent 8,476,425

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Cubist Pharms Llc ZERBAXA ceftolozane sulfate; tazobactam sodium POWDER;IV (INFUSION) 206829-001 Dec 19, 2014 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 8,476,425

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,685,957 Tazobactam arginine compositions ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Baxter
Medtronic
Cerilliant
US Department of Justice
Merck
Fuji
Covington
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.